-70.3%
MRNA vs AMC
-99.5%
+29.2%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | AMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -3.9% | +0.5% | -2.8% |
| 7D | -10.1% | -6.8% | -3.3% | -9.1% |
| 30D | +126.7% | +1.7% | +125.1% | +127.2% |
| 3M | +184.1% | +26.8% | +157.3% | +171.5% |
| 6M | +143.3% | +117.7% | +25.6% | +112.6% |
| YTD | +359.9% | +57.7% | +302.2% | +317.6% |
| 1Y | +454.2% | -12.5% | +466.6% | +444.3% |
| 3Y | +26.0% | -65.7% | +91.7% | +29.8% |
| 5Y | -70.3% | -99.5% | +29.2% | -52.3% |
| All | -70.3% | -99.5% | +29.2% | -52.3% |
Cumulative growth
Daily Returns
Daily percentage return beside AMC.
Daily Out/Under-Performance
Portfolio return minus AMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded AMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling